What Flexion Therapeutics Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Kwo Elizabeth | Director | Nov 19 | Disposition to Issuer · D | −4,500 | $8.50 | −$38.3K | 0 |
| Andrews William T. | Chief Medical Officer | Nov 19 | Disposition to Issuer · D | −34,250 | $8.50 | −$291K | 0 |
| Wentworth Kerry | Chief Regulatory Officer | Nov 19 | Disposition to Issuer · D | −6,000 | $8.50 | −$51K | 0 |
| Wentworth Kerry | Chief Regulatory Officer | Nov 19 | Disposition to Issuer · D | −140,843 | $8.50 | −$1.2M | 0 |
| Mahaffy Patrick J | Director | Nov 19 | Disposition to Issuer · D | −39,824 | $8.50 | −$339K | 0 |
| Lukatch Heath | Director | Nov 19 | Disposition to Issuer · D | −9,000 | $8.50 | −$76.5K | 0 |
| Newtyn Management, Llc | 10% owner | Nov 19 | Tender Offer · U | −5,900,000 | — | — | 0 |
| Stejbach Mark | Director | Nov 19 | Disposition to Issuer · D | −12,631 | $8.50 | −$107K | 0 |
| Driscoll Frederick W | Chief Financial Officer | Nov 19 | Disposition to Issuer · D | −30,680 | $8.50 | −$261K | 0 |
| Clayman Michael D. | President and CEO | Nov 19 | Disposition to Issuer · D | −388,683 | $8.50 | −$3.3M | 0 |
| Clayman Michael D. | President and CEO | Nov 19 | Disposition to Issuer · D | −24,600 | $8.50 | −$209K | 0 |
| Clayman Michael D. | President and CEO | Nov 19 | Disposition to Issuer · D | −373,769 | $8.50 | −$3.18M | 0 |
| Clayman Michael D. | President and CEO | Nov 19 | Disposition to Issuer · D | −335,498 | $8.50 | −$2.85M | 0 |
| Willwerth Christina | Chief Strategy Officer | Nov 19 | Disposition to Issuer · D | −141,241 | $8.50 | −$1.2M | 0 |
| Muzikant Adam | Chief Business Officer | Nov 19 | Disposition to Issuer · D | −103,666 | $8.50 | −$881K | 0 |
| Layman Melissa | Chief Commercial Officer | Nov 19 | Disposition to Issuer · D | −103,956 | $8.50 | −$884K | 0 |
| Colella Samuel D | Director | Nov 19 | Disposition to Issuer · D | −250 | $8.50 | −$2.13K | 0 |
| Colella Samuel D | Director | Nov 19 | Disposition to Issuer · D | −19,653 | $8.50 | −$167K | 0 |
| Colella Samuel D | Director | Nov 19 | Disposition to Issuer · D | −943 | $8.50 | −$8.02K | 0 |
| Colella Samuel D | Director | Nov 19 | Disposition to Issuer · D | −388,683 | $8.50 | −$3.3M | 0 |
Loading...
